UBS starts Biohaven at buy, cites diverse pipeline
https://seekingalpha.com/news/4064106-ubs-starts-biohaven-at-buy-cites-diverse-pipeline?source=feed_sector_healthcare
Feb 07, 2024 - UBS has initiated coverage of Biohaven (BHVN) with a buy rating, citing its attractive valuation and diverse pipeline. The investment bank said it was “bullish
0
UBS Q4 Earnings Decline Y/Y on Higher Expenses, Revenues Up
https://www.zacks.com/stock/news/2222803/ubs-q4-earnings-decline-y-y-on-higher-expenses-revenues-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2222803
Feb 07, 2024 - A rise in operating expenses hinders UBS' Q4 earnings. Though the Business divisions' performances have not been so impressive, it managed to report higher revenues.
0
UBS beats earnings expectations, announces up to $1 billion share buyback
https://www.cnbc.com/2024/02/06/ubs-beats-earnings-expectations-announces-up-to-1-billion-share-buyback.html
Feb 06, 2024 - Swiss banking giant UBS on Tuesday narrowly beat fourth-quarter earnings expectations and announced that it would recommence share buybacks worth $1 billion in the second half of the year.
0
UBS reports mixed Q4 results; confirms financial targets, reinstates share buyback in 2H24
https://seekingalpha.com/news/4062951-ubs-gaap-eps-of--009-misses-by-242-revenue-of-1086b-beats-by-90m?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Feb 05, 2024 - UBS (UBS) reports 4Q/FY23 results and confirms financial targets, plans to propose $0.70 dividend per share, +27% Y/Y, and to reinstate share repurchases in 2H24.
Q4 GAAP EPS of -$0.09 mi..
0
Gold prices to hit $2,200 and silver could 'really shine' this year, UBS says
https://seekingalpha.com/news/4062949-gold-prices-to-hit-2200-and-silver-could-really-shine-this-year-ubs-says?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Feb 05, 2024 - Gold and silver prices are expected to rise further in 2024 as the Federal Reserve eventually will start cutting interest rate, UBS precious metals strategist Joni teves says.
0
UBS Group: Upside Depends On Growing Book Value
https://seekingalpha.com/article/4665637-ubs-group-upside-depends-on-growing-book-value?source=feed_tag_editors_picks
Jan 28, 2024 - UBS Group AG is the last major Swiss bank after acquiring Credit Suisse for $3 billion in 2023. See why I rate UBS stock as a hold for now.
0
UBS cuts Cytokinetics to neutral, sees takeout valuation at $105
https://seekingalpha.com/news/4057887-ubs-cuts-cytokinetics-to-neutral-sees-takeout-valuation-at-105?source=feed_sector_healthcare
Jan 24, 2024 - UBS has downgraded Cytokinetics (CYTK) to neutral, commenting that it believes some of the potential M&A premium has already been baked into the stock’s price. Read more here.
0
UBS CEO says Swiss public 'indoctrinated' to worry about bank's balance sheet
https://www.cnbc.com/2024/01/17/ubs-ceo-says-swiss-public-indoctrinated-to-worry-about-banks-balance-sheet.html
Jan 17, 2024 - UBS CEO Sergio Ermotti on Wednesday said people with concerns about the size of the bank's balance sheet "are getting indoctrinated" by academics.
0
Stock leaders for 2030 in Health Tech - UBS
https://seekingalpha.com/news/4055326-stock-leaders-for-2030-in-health-tech-ubs?source=feed_sector_healthcare
Jan 16, 2024 - UBS' list of health tech stocks with opportunities for growth through 2030.
0
Swiss regulator calls for more powers after Credit Suisse collapse
https://www.cnbc.com/2023/12/19/swiss-regulator-calls-for-more-powers-after-credit-suisse-collapse.html
Dec 19, 2023 - Switzerland's financial regulator on Tuesday called for greater legal powers and vowed to adapts its approach in the wake of the Credit Suisse collapse.
0